Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
LENSAR
LNSR
LENSAR
Global System Placements Will Improve Operating Room Efficiency
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 1 Analyst
Published
10 May 25
Updated
24 Jul 25
2
Set Fair Value
0
votes
Share
AnalystConsensusTarget
's Fair Value
US$15.00
14.9% undervalued
intrinsic discount
24 Jul
US$12.76
Loading
1Y
218.2%
7D
-2.1%
Author's Valuation
US$15.0
14.9% undervalued
intrinsic discount
AnalystConsensusTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystConsensusTarget Fair Value
US$15.0
14.9% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-57m
121m
2018
2020
2022
2024
2025
2026
2028
Revenue US$120.6m
Earnings US$942.2k
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
27.83%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.51%
Calculation
US$942.16k
Earnings '28
x
234.58x
PE Ratio '28
=
US$221.02m
Market Cap '28
US$221.02m
Market Cap '28
/
12.36m
No. shares '28
=
US$17.88
Share Price '28
US$17.88
Share Price '28
Discounted to 2025 @ 7.08% p.a.
=
US$14.56
Fair Value '25